 
            
            - 
                    JM-221
-  names: Platinum, amminebis(butanoato-O)dichloro(cyclohexanamine)-, (OC-6-43)-
- CAS號: 129551-91-3MDL Number:
- MF(分子式): C14H30Cl2N2O4Pt MW(分子量): 556.39
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 貨品編碼 | 規(guī)格 | 純度 | 價格 (¥) | 現(xiàn)價(¥) | 特價(¥) | 庫存描述 | 數(shù)量 | 總計 (¥) | 
|---|
| 中文別名 | JM-221 | 
| 英文別名 | JM-221, JM 221, JM221 | 
| CAS號 | 129551-91-3 | 
| Inchi | 1S/C6H13N.2C4H8O2.2ClH.H3N.Pt/c7-6-4-2-1-3-5-6;2*1-2-3-4(5)6;;;;/h6H,1-5,7H2;2*2-3H2,1H3,(H,5,6);2*1H;1H3;/q;;;;;;+4/p-4 | 
| InchiKey | XMOWMXXEICQRQH-UHFFFAOYSA-J | 
| 分子式 Formula | C14H30Cl2N2O4Pt | 
| 分子量 Molecular Weight | 556.39 | 
| 溶解度Solubility | |
| 性狀 | Solid powder | 
| 儲藏條件 Storage conditions | Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years). | 
| 產(chǎn)品說明 | JM-221(CAS:129551-91-3):僅限應(yīng)用于工業(yè)或者科學(xué)研究過程中非醫(yī)療目的,不應(yīng)用于人類或動物的臨床診斷以及治過程療,該產(chǎn)品非藥用,非食用。 | 
| Introduction | JM-221 is a novel platinum(IV) dicarboxylate complex exhibiting enhanced cytotoxicity in human ovarian carcinoma cell line when compared to Cisplatin. Comparison with platinum accumulation from Cisplatin suggests that the increased cytotoxicity of JM-221 may be related to increased accumulation within the cell. JM-221 is more lipophilic than Cisplatin, which may account for improved uptake in Cisplatin resistant cells. | 
| Application1 | |
| Application2 | |
| Application3 | 
| [1]Orr RM, O'Neill CF, Nicolson MC, Barnard CF, Murrer BA, Giandomenico CM, Vollano JF, Harrap KR. Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin. Br J Cancer. 1994 Sep;70(3):415-20. PubMed PMID: 8080724; PubMed Central PMCID: PMC2033379. | 
| [2]McKeage MJ, Abel G, Kelland LR, Harrap KR. Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitro. Br J Cancer. 1994 Jan;69(1):1-7. PubMed PMID: 8286188; PubMed Central PMCID: PMC1968778. | 
| [3] Mellish KJ, Kelland LR, Harrap KR. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin. Br J Cancer. 1993 Aug;68(2):240-50. PubMed PMID: 8347478; PubMed Central PMCID: PMC1968570. | 
| [4] Kelland LR, Murrer BA, Abel G, Giandomenico CM, Mistry P, Harrap KR. Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res. 1992 Feb 15;52(4):822-8. PubMed PMID: 1737343. | 
- 相關(guān)產(chǎn)品
- 
                < >
- 推薦產(chǎn)品
- 
                < >
- 最新產(chǎn)品
- 
                    < >
新聞

怎么做細胞爬片免疫組化染色實驗
細胞爬片免疫組化染色,是通過細胞爬片是讓玻片浸在細胞培養(yǎng)基內(nèi),細胞在玻片上生長,主要用于組織學(xué),免疫組織化學(xué)...
2020/7/20 22:04:33

提取病毒RNA的實驗方法
提取病毒RNA方法分別有:異硫氰酸胍的提取病毒RNA方法、TRIzol LS提取法、Trizol法提取法等等...
2020/7/22 20:29:26

9月開學(xué)季——助研新學(xué)期 范德送好禮
2025/8/28 15:30:55

Waxfilm 實驗室封口膜:技術(shù)與國際市場的雙重突破
在實驗室耗材領(lǐng)域,封口膜是保障實驗準確性與穩(wěn)定性的關(guān)鍵產(chǎn)品之一。近年來,Waxfilm?實驗室封口膜憑借其卓...
2025/5/13 13:03:40

Waxfilm實驗室封口膜的5大突破
Waxfilm實驗室封口膜作為生物功能膜領(lǐng)域的國產(chǎn)技術(shù)突破和品牌突破,是生物領(lǐng)域中國技術(shù)發(fā)展的縮影。
2025/5/6 17:02:07

各種微流控芯片鍵合方法的優(yōu)缺點
微流控芯片鍵合:目前主要有激光焊接、熱壓鍵合、膠鍵合、超音波焊接,每種方法都有各自的優(yōu)缺點。本文主要介紹聚酯...
2023/7/28 10:43:09

新一代微流控鍵合解決方案
微流控鍵合解決方案:微流控芯片制造的一個重要環(huán)節(jié),也是最容易被忽視的--芯片鍵合。其中一個重要因素是:微流控...
2023/7/27 12:44:28

熒光素鉀鹽使用說明
D-熒光素鉀鹽(K+)設(shè)計用于體外和體內(nèi)生物發(fā)光測定。D-熒光素的質(zhì)量和純度對于獲得良好和可重復(fù)的結(jié)果至關(guān)重...
2023/7/20 11:05:11

如何選BSA(牛血清白蛋白)
如何選BSA(牛血清白蛋白):牛血清白蛋白(BSA)有多種形式,如何選擇適合自己的牛血清白蛋白(BSA)是一...
2023/2/14 13:09:18

牛血清白蛋白(BSA)常見問題
牛血清白蛋白(BSA)常見問題:牛血清白蛋白(BSA)在實驗室中是通用的,可用于蛋白質(zhì)印跡、細胞組織培養(yǎng)、P...
2022/10/19 9:39:51
 
          


 購物車
購物車 



